This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2006-2023.
Company Filing History:
Years Active: 2006-2023
Title: F Michael Hoffmann: Innovator in Cancer Research
Introduction
F Michael Hoffmann is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of cancer research, particularly through his innovative work on inhibitors of transforming growth factor-beta signaling. With a total of 3 patents, Hoffmann's research has the potential to impact cancer treatment significantly.
Latest Patents
Hoffmann's latest patents include groundbreaking technologies related to Biemamides and their scaffolds. These patents focus on isolated compounds that inhibit TGF-β signaling and TGF-β induced epithelial mesenchymal transitions (EMT). The methods outlined in these patents aim to treat certain cancers that involve TGF-β signaling and EMT, showcasing Hoffmann's commitment to advancing medical science.
Career Highlights
Hoffmann is associated with the Wisconsin Alumni Research Foundation, where he continues to develop his innovative ideas. His work has garnered attention in the scientific community, and he is recognized for his contributions to cancer research.
Collaborations
Hoffmann has collaborated with esteemed colleagues such as Timothy Bugni and Douglas Braun. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
F Michael Hoffmann stands out as a dedicated inventor whose work in cancer research is paving the way for new treatment options. His innovative patents and collaborations reflect his commitment to improving healthcare outcomes.